Bright Eyes Drops for Cataracts

N-Acetyl-Carnosine (NAC) Bright Eyes Drops Naturally Dissolve Cataracts!

Buy Multi-month supply and save!
1 month= $90
2 month= $170 (save $10!)
3 month= $245 (save $25!)
6 month= $465 (save $75!)

Ethos Endymion Bright Eyes Drops: 
Maintaining eye health is a major concern as we age. As we get older our eyes have a harder time fighting off free radicals that cause oxidative stress. This highly oxidised environment within cells comes about as a result of a chemical reaction from exposure to oxygen and sunlight. Since the lens of the eye acts as a light shield for the retina, it’s no wonder it takes all the oxidative punishment. The destructive action of free radicals (they are oxidising agents) also destroys enzymes that are needed to maintain cellular metabolism. And, since blood flow decreases with age, the eye is further deprived of other essential nutrients for health.

Although many praise the benefits of dietary supplements, another way of preventing and treating eye disorders is through topical solutions.

Ethos Endymion Bright Eyes is one of the most advanced eye formulas that offer protection from free radicals because of its unique formulation of lubricants, an anti-glycating agent, and antioxidant. Glycation occurs as a result of nonenzymatic binding of sugar to protein, which eventually leads to tissue damage. It’s a condition that increases with age.

The newly formulated Endymion Bright Eyes contains 1% N-Acetyl-L-Carnosine, a naturally occurring antioxidant and anti-glycating agent that, when topically applied, can penetrate and protect the lipid tissues of the eye against light damage. Bright Eyes will help to diminish free radical damage and the harmful effects of glycosylation associated with degenerative eye disease.

Bright Eyes Ingredients:
Antioxidants: N-Acetyl-Carnosine (NAC) - 1.0%
Glycerin (lubricant) - 1.0%
Hydroxypropylmethylcellulose Sodium (lubricant) - 0.15%
Sterile Water (ophthalmic grade isotonic solution, pH 6.3 to 6.5)
Buffered with Boric Acid, Citric Acid and Potassium Bicarbonate
And, as a preservative, Purified Benzyl Alcohol 
 
Other Information:

• Bright Eyes is 100% hypoallergenic.
• Bright Eyes is 100% free of animal ingredients and may be freely used by vegetarians.
• Bright Eyes is 100% safe and suitable for use on pets and other animals.

Bright Eyes Recommended Usage:
The recommended use for Bright Eyes NAC eyes drops is to apply 1 to 2 drops in each eye daily. Those with any kind of eye problem may want to apply 1 to 2 drops several times a day.

Each 5ml bottle should last 30 days at two drops per day or 15 days at four drops per day. A box contains 2 x 5ml bottles; therefore each package can last between 30 and 60 days which represents excellent value for money.

Unopened bottles should be stored in the dark in the refrigerator.

The use of Carnosine as an anti-senescence supplement

From our investigations, we have reported that eye drops containing 20 mM carnosine were used to treat 96 patients aged 60 years old having senile cataract of various degrees of maturity, with the duration of the disease from 2 to 21 years. The method is that after stopping all other anti-cataract drugs, patients instilled 1-2 drops of the carnosine containing solution in each eye 3-4 times each day for a period of treatment ranging from 3-6 months. The level of eyesight improvement and the change of lens transparency were considered as an evaluation index of the curative effect of carnosine.

The result shows that carnosine gives a profound effect on primary senile cataract, the effective rate being 100%.

For mature senile cataract, the effect rate is 80%, and positive effects were observed with other types of cataract.

It is significant that no side effect has been found in the observed cases. During recent years, we have also applied carnosine drops containing the same content to nearly 1,000 patients with senile cataract. Our research findings (ready to be published) show similar results.

In addition, we applied carnosine drops to patients aged 48-60 years with various degrees of eyesight impairment but without symptoms of cataract. The course of treatment is from 2 to 6 months. The results demonstrate that carnosine appears to alleviate eye tiredness and comparatively improve eyesight (obviously improve eyesight, giving more clear vision). Subjects reported that carnosine could brighten and relax their eyes.

It is an important point that all the above research on the medical application of carnosine has statistical significance.

The efficacy of N-acetylcarnosine in the treatment of cataracts

Babizhayev MA, Deyev AI, Yermakova VN, Semiletov YA, Davydova NG, Doroshenko VS, Zhukotskii AV, Goldman IM.

PURPOSE: To evaluate the effects of 1% N-acetylcarnosine (NAC) solution on lens clarity over 6 and 24 months in patients with cataracts. TRIAL DESIGN: Randomised, placebo-controlled study.

PARTICIPANTS: 49 subjects (76 affected eyes) with an average age of 65.3 +/- 7.0 years with a diagnosis of senile cataract with minimum to advanced opacification in various lens layers. METHODS: 26 patients (41 eyes) were allocated to topical NAC 1% eyedrops twice daily.

The control group consisted of 13 patients (21 eyes) who received placebo eyedrops and 10 patients (14 eyes) who did not receive eyedrops.

MAIN OUTCOME MEASURES: All patients were evaluated at entry and followed up every 2 months for a 6-month period (trial 1), or at 6-month intervals for a 2-year period (trial 2), for best-corrected visual acuity and glare testing. In addition, cataract was measured using stereocinematographic slit-images and retro-illumination examination of the lens. Digital analysis of lens images displayed light scattering and absorbing centres in two- and three-dimensional scales.

RESULTS: The overall intra-reader reproducibility of cataract measurements (image analysis) was 0.830, and glare testing 0.998. After 6 months, 90% of NAC-treated eyes showed improvement in best corrected visual acuity (7 to 100%) and 88.9% showed a 27 to 100% improvement in glare sensitivity.

Topographic studies indicated fewer areas of posterior subcapsular lens opacity and 41.5% of treated eyes had improvement in image analysis characteristics. The overall ratios of image analysis characteristics at 6 months compared with baseline measures were 1.04 and 0.86 for the control and NAC-treated group, respectively (p < 0.001). The apparent benefits of treatment were sustained after 24 months' treatment.

No treated eyes demonstrated worsening of vision. The overall visual outcome in the control group showed significant worsening after 24 months in comparison with both baseline and the 6-month follow-up examination. The overall clinical results observed in the NAC-treated group by the 24-month period of examination differed significantly (p < 0.001) from the control group in the eyes with cortical, posterior subcapsular, nuclear or combined lens opacities. Tolerability of NAC eyedrops was good in almost all patients, with no reports of ocular or systemic adverse effects.

CONCLUSION: Topical NAC shows potential for the treatment and prevention of cataracts.

Publication Types:

Clinical Trial
Randomised Controlled Trial
 
The photographs below show images of a lens with senile cataract (corticonuclear opacities, grade 4, age 75 years, female), and the subsequent slit images in optical section documenting in the focal plane: (a) marked light scattering in the nucleus and posterior cortical region outlined by the lens optical scanning with the focal plane movement inside the lens thickness; (b) light scattering in the anterior subcapsular, anterior cortical and nuclear regions of the lens; retro-illumination lens images with a focal plane positioned (c) onto the iris and (d) on the posterior lens layers. Opacities in the cortical layers are demonstrated as the white background inclusions in the boundary of the pupil locally masked by the flashlight article. (e) the neutral density step reference wedge captured in the plane of the camera focus and allowing correction for variations in film development and flashlight output. 
 

In the NAC-treated group, 6-month follow-up showed an improvement in VA (7-100%) in 37 of the 41 treated eyes and a significant improvement in glare sensitivity at red and green targets (27-100%) was documented in 16 of the 18 eyes tested. A significant improvement in lens clarity was found in 17 of the 41 eyes as documented by a significant decrease of M and H characteristics during image grading. The NAC-treated eyes had statistically significant differences in VA, glare sensitivity and characteristics of image analysis compared with the control group (p < 0.001) at this time point, as supported by the overall t-test results of the ratio of the follow-up data to the baseline values.

N-Acetyl-Carnosine (NAC) Bright Eyes Drops naturally dissolve cataracts!

Eye Problems:   
If you were asked which sense you would regret losing the most, you'd probably say your eyesight. Vision impairment is one of the most feared disabilities. Yet, according to the National Eye Institute, at least half of all cases of blindness can be prevented. But the number of people who suffer from visual impairment continues to grow at an alarming rate.  
    
Near-sightedness, far-sightedness, and astigmatism are common symptoms of living in the twentieth century. As we age, many of us face more serious eye problems. Cataracts, the leading cause of blindness in the world, affects nearly 20.5 million Americans; 2.2 million have been diagnosed with glaucoma, and another 2 million are unaware they have it; and more than 1.6 million Americans over 60 have advanced macular degeneration, the most common cause of blindness and visual impairment in Americans over 60.  
   
The top 2 causes of serious visual impairment are cataracts and macular degeneration.
    
Cataracts:   
Cataracts are the leading cause of decreased vision in adults older than 65 and is the most common surgical procedure for elderly people. But you can get an "age-related" cataract when you're in your 40s or 50s, although most likely it will be small and not rob you of your vision. Only 15 percent of people are affected with cataracts by age 55, but this figure jumps to 50 percent by age 75, and 90 percent by age 85. It's important to note, however, that cataracts worsen over time … so it's never too late-or early-to try to prevent them and/or treat them!
  
What is a cataract?  
A cataract is an opaque spot on the lens of the eye that you can't see through.
The lens lies behind the iris and the pupil, and works like a camera lens. It focuses light onto the retina at the back of the eye, where an image is recorded. The lens also adjusts the eye's focus, which allows you to see things clearly, up close, and far away.

The lens is made of mostly water and protein. But as we age, some of the protein may clump together and start to cloud a small area of the lens. This is a cataract. Over time, the cataract may grow larger and cloud more of the lens, making it harder to see.

The haze can vary in size, density, and location, which means its effect on your vision, will also vary. At first, many people experience an overall reduction in their vision; they may need more light to read by, or may have difficulty reading street signs while driving. A cataract can also affect depth perception, which is particularly dangerous for the elderly who are more prone to falling.
  
Common Symptoms of Cataracts include: 

• Cloudy, fuzzy, foggy, or filmy vision
• Changes in the way you see colours
• Problems driving at night because headlights seem too bright
• Problems with glare from lamps or the sun
• Frequent changes in your eyeglass prescription
• Double vision
• Better near vision (temporarily in farsighted people only).

Note: These symptoms also can be signs of other eye problems.

N-Acetyl-Carnosine (NAC) Bright Eyes Drops Naturally Dissolve Cataracts!

Ethos Endymion Bright Eyes Drops: 
Maintaining eye health is a major concern as we age. As we get older our eyes have a harder time fighting off free radicals that cause oxidative stress. This highly oxidised environment within cells comes about as a result of a chemical reaction from exposure to oxygen and sunlight. Since the lens of the eye acts as a light shield for the retina, it’s no wonder it takes all the oxidative punishment. The destructive action of free radicals (they are oxidising agents) also destroys enzymes that are needed to maintain cellular metabolism. And, since blood flow decreases with age, the eye is further deprived of other essential nutrients for health.

Although many praise the benefits of dietary supplements, another way of preventing and treating eye disorders is through topical solutions.

Ethos Endymion Bright Eyes is one of the most advanced eye formulas that offer protection from free radicals because of its unique formulation of lubricants, an anti-glycating agent, and antioxidant. Glycation occurs as a result of nonenzymatic binding of sugar to protein, which eventually leads to tissue damage. It’s a condition that increases with age.

The newly formulated Endymion Bright Eyes contains 1% N-Acetyl-L-Carnosine, a naturally occurring antioxidant and anti-glycating agent that, when topically applied, can penetrate and protect the lipid tissues of the eye against light damage. Bright Eyes will help to diminish free radical damage and the harmful effects of glycosylation associated with degenerative eye disease.

The use of Carnosine as an anti-senescence supplement

From our investigations, we have reported that eye drops containing 20 mM carnosine were used to treat 96 patients aged 60 years old having senile cataract of various degrees of maturity, with the duration of the disease from 2 to 21 years. The method is that after stopping all other anti-cataract drugs, patients instilled 1-2 drops of the carnosine containing solution in each eye 3-4 times each day for a period of treatment ranging from 3-6 months. The level of eyesight improvement and the change of lens transparency were considered as an evaluation index of the curative effect of carnosine.

The result shows that carnosine gives a profound effect on primary senile cataract, the effective rate being 100%.

For mature senile cataract, the effect rate is 80%, and positive effects were observed with other types of cataract.

It is significant that no side effect has been found in the observed cases. During recent years, we have also applied carnosine drops containing the same content to nearly 1,000 patients with senile cataract. Our research findings (ready to be published) show similar results.

In addition, we applied carnosine drops to patients aged 48-60 years with various degrees of eyesight impairment but without symptoms of cataract. The course of treatment is from 2 to 6 months. The results demonstrate that carnosine appears to alleviate eye tiredness and comparatively improve eyesight (obviously improve eyesight, giving more clear vision). Subjects reported that carnosine could brighten and relax their eyes.

It is an important point that all the above research on the medical application of carnosine has statistical significance.

Cataracts Eye Treatment - Ethos Care for Eyes
 
Of the many different human senses, eyesight is probably the most highly prized, yet the majority of us take it so much for granted. Ethos are dedicated to bringing you cutting-edge products to help in the fight against visual impairments such as senile cataracts and age-related macular degeneration (AMD).
 
Nac Eye Drops or Cataract Surgery?

Nac Eye Drops

NAC eye drops, to be used for the treatment of cataract, require 2 drops into each eye, twice daily for a period of 6-12 months (although due to the nature of senile cataract a permanent continuance may be advisable).

Clinical trials indicate an eye condition improvement of 41.5% to 100% for patients within a 6-month period with sustainable results 24-months later.

Another study on 96 patients aged 60 years old having senile cataract of various degrees of maturity, with the duration of the disease from 2 to 21 years, showed that carnosine gives a profound effect on primary senile cataract, the effective rate being 100%.

For mature senile cataract, the effect rate is 80%, and positive effects were observed with other types of cataract.

The findings from a recent report say "A need exists for development of therapeutic agents to slow age-related loss of antioxidant's in the nucleus of the human lens to delay the onset of cataract". Free radicals for the most part cause cataracts and other senile eye disorders. Oxidative stress is also a contributing factor in the development of macular degeneration.

Degenerative changes in the eye often begin in middle age, resulting in macular degeneration, glaucoma, cataracts and other forms of retinopathy in later life.

"Already, after just seven weeks of using them the white film has cleared from her eyes and there is now just a very small patch left in the corners. She can now see my finger again which she couldn't before and everyday like clockwork she reminds me that it's time for her drops." - Mary & Chanahhei - Middlesex

Cataract Surgery

Phacoemulsification, or phaco. Your doctor makes a small incision on the side of the cornea, the clear, dome-shaped surface that covers the front of the eye. The doctor then inserts a tiny probe into the eye. This device emits ultrasound waves that soften and break up the cloudy centre of the lens so it can be removed by suction. Most cataract surgery today is done by phaco, which is also called small incision cataract surgery.

Extracapsular surgery. Your doctor makes a slightly longer incision on the side of the cornea and removes the hard center of the lens. The remainder of the lens is then removed by suction.

In most cataract surgeries, the removed lens is replaced by an intraocular lens (IOL). An IOL is a clear, artificial lens that requires no care and becomes a permanent part of your eye. With an IOL, you'll have improved vision because light will be able to pass through it to the retina. Also, you won't feel or see the new lens.

Sometimes a part of the natural lens that is not removed during cataract surgery becomes cloudy and may blur your vision.

This is called an after-cataract. An after-cataract can develop months or years later.

When our eyes are young they contain high concentrations of natural antioxidants that protect against cataract, macular degeneration and other ocular disorders.

As we enter middle age, synthesis of the antioxidant glutathione is reduced, resulting in excessive free radical damage.

Antioxidant supplements (Ethos élan vital) have been shown to help protect against senile eye disorders but unfortunately, aging diminishes circulation to the eye, thereby reducing the effectiveness of oral supplements.